{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:37:08Z","timestamp":1783525028133,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,17]]},"DOI":"10.7759\/cureus.77598","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:43:07Z","timestamp":1737160987000},"source":"Crossref","is-referenced-by-count":2,"title":["Iron-Deficiency Anemia in Chronic Kidney Disease: A Literature Review of Its Pathophysiology, Diagnosis, and Management"],"prefix":"10.7759","author":[{"given":"Saba","family":"Kazmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoriia","family":"Zarovniaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Cortez Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehej","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summayya","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2023.100677","article-title":"Iron-deficiency anemia in CKD: A narrative review for the kidney care team","volume":"5","author":"Hain D","year":"2023","unstructured":"Hain D, Bednarski D, Cahill M, et al.. Iron-deficiency anemia in CKD: A narrative review for the kidney care team. Kidney Med. 2023, 5:100677. 10.1016\/j.xkme.2023.100677","journal-title":"Kidney Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.05.020","article-title":"Treatment of iron deficiency anemia in CKD and end-stage kidney disease","volume":"6","author":"Guti\u00e9rrez OM","year":"2021","unstructured":"Guti\u00e9rrez OM. Treatment of iron deficiency anemia in CKD and end-stage kidney disease. Kidney Int Rep. 2021, 6:2261-9. 10.1016\/j.ekir.2021.05.020","journal-title":"Kidney Int Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01524-6","article-title":"Burden of anemia in chronic kidney disease: Beyond erythropoietin","volume":"38","author":"Hanna RM","year":"2021","unstructured":"Hanna RM, Streja E, Kalantar-Zadeh K. Burden of anemia in chronic kidney disease: Beyond erythropoietin. Adv Ther. 2021, 38:52-75. 10.1007\/s12325-020-01524-6","journal-title":"Adv Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-020-02663-z","article-title":"Biomarkers of iron metabolism in chronic kidney disease","volume":"53","author":"Tomasz G","year":"2021","unstructured":"Tomasz G, Ewa W, Jolanta M. Biomarkers of iron metabolism in chronic kidney disease. Int Urol Nephrol. 2021, 53:935-44. 10.1007\/s11255-020-02663-z","journal-title":"Int Urol Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00244.2020","article-title":"The potential role of Na-K-ATPase and its signaling in the development of anemia in chronic kidney disease","volume":"320","author":"Maxwell KD","year":"2021","unstructured":"Maxwell KD, Chuang J, Chaudhry M, et al.. The potential role of Na-K-ATPase and its signaling in the development of anemia in chronic kidney disease. Am J Physiol Renal Physiol. 2021, 320:F234-42. 10.1152\/ajprenal.00244.2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12061191","article-title":"Anemia of chronic kidney disease-A narrative review of its pathophysiology, diagnosis, and management","volume":"12","author":"Badura K","year":"2024","unstructured":"Badura K, Janc J, W\u0105sik J, et al.. Anemia of chronic kidney disease-A narrative review of its pathophysiology, diagnosis, and management. Biomedicines. 2024, 12:1191. 10.3390\/biomedicines12061191","journal-title":"Biomedicines"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2019000035","article-title":"New diagnostic tools for delineating iron status","volume":"2019","author":"Ginzburg YZ","year":"2019","unstructured":"Ginzburg YZ. New diagnostic tools for delineating iron status. Hematology Am Soc Hematol Educ Program. 2019, 2019:327-36. 10.1182\/hematology.2019000035","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-020-02663","article-title":"Biomarkers of iron metabolism in chronic kidney disease","volume":"53","author":"Tomasz G","year":"2021","unstructured":"Tomasz G, Ewa W, Jolanta M. Biomarkers of iron metabolism in chronic kidney disease. Int Urol Nephrol. 2021, 53:935-44. 10.1007\/s11255-020-02663","journal-title":"Int Urol Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/nu10091173","article-title":"Impact of inflammation on ferritin, hepcidin and the management of iron deficiency anemia in chronic kidney disease","volume":"10","author":"Ueda N","year":"2018","unstructured":"Ueda N, Takasawa K. Impact of inflammation on ferritin, hepcidin and the management of iron deficiency anemia in chronic kidney disease. Nutrients. 2018, 10:1173. 10.3390\/nu10091173","journal-title":"Nutrients"},{"key":"ref10","article-title":"Anemia of chronic kidney disease","author":"Hashmi MF","year":"2024","unstructured":"Hashmi MF, Aeddula NR, Shaikh H, Rout P. Anemia of chronic kidney disease. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.33126","article-title":"Absolute and functional iron deficiency in the US, 2017-2020","volume":"7","author":"Tawfik YMK","year":"2024","unstructured":"Tawfik YMK, Billingsley H, Bhatt AS, Aboelsaad I, Al-Khezi OS, Lutsey PL, Buckley LF. Absolute and functional iron deficiency in the US, 2017-2020. JAMA Netw Open. 2024, 7:e2433126. 10.1001\/jamanetworkopen.2024.33126","journal-title":"JAMA Netw Open"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019020213","article-title":"Iron deficiency in chronic kidney disease: Updates on pathophysiology, diagnosis, and treatment","volume":"31","author":"Batchelor EK","year":"2020","unstructured":"Batchelor EK, Kapitsinou P, Pergola PE, Kovesdy CP, Jalal DI. Iron deficiency in chronic kidney disease: Updates on pathophysiology, diagnosis, and treatment. J Am Soc Nephrol. 2020, 31:456-68. 10.1681\/ASN.2019020213","journal-title":"J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu201","article-title":"FIND-CKD: A randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia","volume":"29","author":"Macdougall IC","year":"2014","unstructured":"Macdougall IC, Bock AH, Carrera F, et al.. FIND-CKD: A randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Nephrol Dial Transplant. 2014, 29:2075-84. 10.1093\/ndt\/gfu201","journal-title":"Nephrol Dial Transplant"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.108","article-title":"Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia","volume":"8","author":"Iolascon A","year":"2024","unstructured":"Iolascon A, Andolfo I, Russo R, et al.. Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia. Hemasphere. 2024, 8:e108. 10.1002\/hem3.108","journal-title":"Hemasphere"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.07.032","article-title":"Iron deficiency in CKD without concomitant anemia","volume":"6","author":"Wish JB","year":"2021","unstructured":"Wish JB, Anker SD, Butler J, Cases A, Stack AG, Macdougall IC. Iron deficiency in CKD without concomitant anemia. Kidney Int Rep. 2021, 6:2752-62. 10.1016\/j.ekir.2021.07.032","journal-title":"Kidney Int Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.22450","article-title":"Effects of iron isomalt side vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia: Two randomized clinical trials","volume":"323","author":"Wolf M","year":"2020","unstructured":"Wolf M, Rubin J, Achebe M, et al.. Effects of iron isomalt side vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia: Two randomized clinical trials. JAMA. 2020, 323:432-43. 10.1001\/jama.2019.22450","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031008","article-title":"Iron therapy in chronic kidney disease: Days of future past","volume":"22","author":"Lee KH","year":"2021","unstructured":"Lee KH, Ho Y, Tarng DC. Iron therapy in chronic kidney disease: Days of future past. Int J Mol Sci. 2021, 22:1008. 10.3390\/ijms22031008","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157063","article-title":"Hepcidin response to iron therapy in patients with non-dialysis dependent CKD: An analysis of the FIND-CKD Trial","volume":"11","author":"Gaillard CA","year":"2016","unstructured":"Gaillard CA, Bock AH, Carrera F, et al.. Hepcidin response to iron therapy in patients with non-dialysis dependent CKD: An analysis of the FIND-CKD Trial. PLoS One. 2016, 11:e0157063. 10.1371\/journal.pone.0157063","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/ndtplus\/sfn175","article-title":"Use of darbepoetin alfa in the treatment of anaemia of chronic kidney disease: Clinical and pharmacoeconomic considerations","volume":"2","author":"Carrera F","year":"2009","unstructured":"Carrera F, Burnier M. Use of darbepoetin alfa in the treatment of anaemia of chronic kidney disease: Clinical and pharmacoeconomic considerations. NDT Plus. 2009, 2:i9-i17. 10.1093\/ndtplus\/sfn175","journal-title":"NDT Plus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2017.09.026","article-title":"Update on anemia in ESRD and earlier stages of CKD: Core curriculum 2018","volume":"71","author":"Fishbane S","year":"2018","unstructured":"Fishbane S, Spinowitz B. Update on anemia in ESRD and earlier stages of CKD: Core curriculum 2018. Am J Kidney Dis. 2018, 71:423-35. 10.1053\/j.ajkd.2017.09.026","journal-title":"Am J Kidney Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5554","article-title":"Cutaneous allergic reaction correlates with anti-erythropoietin antibodies in dialysis patient developing pure red cell aplasia","volume":"10","author":"Badiu I","year":"2022","unstructured":"Badiu I, Diena D, Guida G, Ferrando C, Rapezzi D, Besso L. Cutaneous allergic reaction correlates with anti-erythropoietin antibodies in dialysis patient developing pure red cell aplasia. Clin Case Rep. 2022, 10:e05554. 10.1002\/ccr3.5554","journal-title":"Clin Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/327658-iron-deficiency-anemia-in-chronic-kidney-disease-a-literature-review-of-its-pathophysiology-diagnosis-and-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:43:08Z","timestamp":1737160988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/327658-iron-deficiency-anemia-in-chronic-kidney-disease-a-literature-review-of-its-pathophysiology-diagnosis-and-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.77598","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,17]]}}}